Milind Deshpande
SVP and Chief Scientific Ofc., ACHILLION PHARMACEUTICALS INC.
Companies
- Spero Therapeutics, Inc.Board member Nov 1, 2017 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Spero Therapeutics, Inc. SPRO101,454 shares2$113.1K at $1.11Jun 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 23, 2026Granted 10,000 shares of Spero Therapeutics, Inc.2
- Jun 12, 2025Granted 20,000 shares of Spero Therapeutics, Inc.3
- May 29, 2024Granted 20,000 shares of Spero Therapeutics, Inc.4
- Oct 5, 2023Granted 20,000 shares of Spero Therapeutics, Inc.5
- Sep 15, 2022Granted 15,000 shares of Spero Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 16, 2025
- 4SEC EDGARForm 4 filed May 30, 2024
- 5SEC EDGARForm 4 filed Oct 10, 2023
- 6SEC EDGARForm 4 filed Sep 19, 2022